8-K: Nu Skin Enterprises Reports Third Quarter Results in Line with Guidance, Adjusts Full-Year Outlook

Nu Skin Enterprises announced third-quarter results that met previous guidance, with core business challenges partially offset by strong growth in the Rhyz segment, while also adjusting their full-year outlook due to ongoing pressures.

Summary

• Nu Skin Enterprises reported third-quarter 2024 revenue of $430.1 million, a 13.8% decrease year-over-year, with a 3.4% negative impact from foreign exchange.
• The Rhyz segment showed strong growth with revenue of $73.1 million, a 20.9% increase year-over-year.
• Earnings per share (EPS) were $0.17, compared to $(0.74) in the prior year, or $0.56 excluding an inventory write-off.
• The company experienced a 15% decrease in customers, a 20% decrease in paid affiliates, and a 19% decrease in sales leaders.
• Nu Skin is implementing a revised business model to improve channel activation and customer growth, starting in North America and South Korea.
• A streamlined operating framework and adjusted pricing model are being introduced to improve profitability and customer penetration in developing markets, beginning with Latin America and Southeast Asia.
• The company is accelerating its product portfolio optimization plan to improve gross margin globally.
• For the full year 2024, revenue is now expected to be between $1.70 and $1.73 billion, a 14% to 12% decrease, with a 4% to 3% negative impact from foreign exchange.
• Full-year EPS is projected to be between $(2.32) and $(2.22), or $0.65 to $0.75 excluding restructuring and impairment charges.
• The company saved an additional $15 million in general and administrative expenses during the quarter and is on track to meet the high end of its $45 to $65 million cost-efficiency target for 2024.
• Cash from operations was $31.4 million, inventory levels were reduced by $43 million year-over-year, and debt was paid down.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the significant revenue decline, decrease in key sales metrics, and lowered full-year outlook, although there are some positives in the Rhyz segment and cost-saving measures.

Positives

• The Rhyz segment demonstrated strong growth with a 20.9% increase in revenue.
• The company achieved a gross margin of 70.1%, a significant improvement compared to the prior year.
• Nu Skin saved an additional $15 million in general and administrative expenses during the quarter.
• The company generated $31.4 million in cash from operations and reduced inventory levels by $43 million year-over-year.
• Debt was paid down, further strengthening the balance sheet.

Negatives

• Overall revenue decreased by 13.8% year-over-year, with a 3.4% negative impact from foreign exchange.
• The core Nu Skin business experienced a 15% decrease in customers, a 20% decrease in paid affiliates, and a 19% decrease in sales leaders.
• The company is facing macroeconomic pressures and challenges within the direct selling industry.
• The full-year revenue outlook has been adjusted downwards to $1.70 to $1.73 billion, a 14% to 12% decrease.
• Full-year EPS is projected to be between $(2.32) and $(2.22), or $0.65 to $0.75 excluding restructuring and impairment charges.

Risks

• The company faces challenges in the core Nu Skin business due to macroeconomic pressures and issues within the direct selling industry.
• There is a risk that new initiatives and products may not generate sufficient interest among the sales force and customers.
• Changes in direct selling laws and regulations could negatively impact the business model.
• Economic conditions and competitive pressures in the company's markets pose a risk.
• The company is exposed to risks related to foreign-currency fluctuations and the currency translation impact on the business.
• There are uncertainties regarding the future financial performance of acquired businesses.
• The company faces risks related to accurately predicting and delivering sufficient quantities of products.
• Regulatory risks associated with the company's products could require modifications or inhibit sales.
• The company's future tax-planning initiatives and any adverse results of tax audits pose a risk.

Future Outlook

The company has adjusted its full-year 2024 revenue outlook to $1.70 to $1.73 billion and EPS to $(2.32) to $(2.22), or $0.65 to $0.75 excluding restructuring and impairment charges. Q4 revenue is projected to be between $410 and $445 million and EPS between $(0.09) and $0.01, or $0.19 to $0.29 excluding planned restructuring charges.

Management Comments

• Ryan Napierski, Nu Skin president and CEO, stated that the company achieved results within its previous guidance range, with challenges in the core business partially offset by strong growth in the Rhyz segment.
• Ryan Napierski mentioned the immediate focus is to strengthen the Nu Skin core with a revised business model to improve channel activation and customer growth.
• James D. Thomas, chief financial officer, noted that the company saved an additional $15 million in general and administrative expense and remains on track to meet the high end of its cost-efficiency target.
• James D. Thomas also mentioned that the company generated $31.4 million in cash from operations, reduced inventory levels, and paid down debt.

Industry Context

The announcement reflects the challenges faced by companies in the direct selling industry, with Nu Skin implementing a revised business model to address these issues. The company's focus on cost efficiency and growth in the Rhyz segment aligns with broader trends in the beauty and wellness sectors.

Comparison to Industry Standards

• Nu Skin's revenue decline of 13.8% is worse than some of its competitors in the beauty and wellness space, such as Herbalife, which has shown more resilience in recent quarters.
• The 20.9% growth in the Rhyz segment is a positive outlier compared to the core business, indicating a potential area of strength and future growth.
• The company's gross margin of 70.1% is competitive with industry standards, but the core Nu Skin business margin of 76.5% is higher than some peers, suggesting a strong pricing power in that segment.
• The decrease in customers, paid affiliates, and sales leaders is a concern, as it indicates a potential loss of market share and engagement compared to other direct selling companies.
• The adjusted full-year outlook reflects the challenges faced by the company, which is similar to other companies in the direct selling industry that are facing headwinds.

Stakeholder Impact

• Shareholders will be impacted by the decreased revenue and lowered full-year outlook.
• Employees may be affected by the restructuring and cost-efficiency programs.
• Customers may experience changes in product offerings and pricing.
• Sales leaders and affiliates will be impacted by the revised business model and changes in eligibility requirements.

Next Steps

• The company will focus on strengthening the Nu Skin core with a revised business model.
• A streamlined operating framework and adjusted pricing model will be introduced to improve profitability.
• The company will accelerate its product portfolio optimization plan.
• The company will continue to empower growth in its Rhyz businesses.
• The company will host a conference call with the investment community to discuss the results.

Key Dates

Keywords

Nu Skin, Rhyz, Direct Selling, Revenue, Earnings Per Share, Gross Margin, Operating Margin, Sales Leaders, Paid Affiliates, Customers, Financial Results, Cost Efficiency, Restructuring, Inventory, Beauty, Wellness